Opendata, web and dolomites

GFeed

Safe and discrete gastrostomy tube for enteral feeding improving the delivery of nutrition and patient care.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GFeed project word cloud

Explore the words cloud of the GFeed project. It provides you a very rough idea of what is the project "GFeed" about.

hospital    care    comfort    conceived    replacement    device    small    reducing    bumper    trials    medications    decrease    ageing    human    opening    avoiding    complete    shortcomings    prevents    healthcare    cleaner    internal    gastroenterology    safer    stomach    severe    removal    inside    port    cagr    clogging    body    discrete    overcome    rigid    semi    naturally    million    intervention    population    enteral    patients    pathologies    initial    validation    tubes    time    innovation    patient    expelled    sold    gfeed    swallow    stoma    impairments    unable    demand    global    animal    homecare       chronic    distributed    gain    hygienic    gastrostomy    peg    feed    clinics    valued    replaced    departments    performed    hospitals    planning    dislodgment    free    510    stay    disposable    placed    kit    tube    fed    market    2020    weeks    alternate    displacement    placement    parts    complication    feeding    dismantle    nutrition    commercialization    settings    complies    trauma    emergency    delivers    17    feasibility    length    reduce    clinical    accidental    solution    driving    pharmacies    adoption    insert    2015    gastroenterologist   

Project "GFeed" data sheet

The following table provides information about the project.

Coordinator
FIDMI MEDICAL LTD 

Organization address
address: 17 TCHELET STREET
city: M.P Misgav
postcode: 2017400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://www.fidmimedical.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-12-01   to  2016-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FIDMI MEDICAL LTD IL (M.P Misgav) coordinator 50˙000.00

Map

 Project objective

Patients unable to swallow for long time due to severe pathologies are fed by gastrostomy tubes that deliver nutrition and medications directly into the stomach. GFeed provide a discrete solution for initial placement, replacement, and complete removal of enteral feeding device that overcome most of the shortcomings of currently used tubes. The semi-rigid internal bumper prevents accidental dislodgment and it is safer for the stoma opening. A disposable insert placed inside the feeding port delivers the nutrition into the stomach. This is replaced every 1-2 weeks, avoiding clogging and making the tube cleaner and more hygienic. The internal bumper is conceived to dismantle in small parts that are naturally expelled from the body for trauma free-removal. G-Feed complies with EU future challenge to face impairments due to ageing population and to reduce the length of hospital stay, that is driving the demand of enteral feeding devices in alternate care and homecare settings. The global market of PEG tubes, replacement tubes, and other gastrostomy tubes is valued $510 million in 2015 and growing at a CAGR of 5.5%. Over 17 million PEG tube procedures are expected in Europe and US by 2020. The initial placement kit is addressed to gastroenterology departments in hospitals and clinics, while the disposable insert is distributed to pharmacies and sold directly to the end-users, namely the enteral fed patients. GFeed adoption by gastroenterologist and their patients will enhance patient comfort and improve the delivery of nutrition by avoiding tube clogging, and will decrease healthcare cost by reducing the need for emergency intervention for displacement and/or complication. During phase 1, a feasibility study will be carried out, as well as the planning of clinical trials in chronic animal and human patient that will be performed during the whole innovation project, to gain the validation needed to bring the product to the commercialization.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GFEED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GFEED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More  

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

AutoCRAT (2020)

Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis

Read More